Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Illumina raises $40M for accelerator matching fund

    Illumina Inc. (NASDAQ:ILMN) raised $40 million from Viking Global Investors for its Accelerator Boost Capital fund, which will provide dollar-for-dollar matching funds for graduates of its Illumina Accelerator. The …

    Published on 2/26/2015
  • FINANCIAL NEWS: Lyric debuts with $20.4M series A

    Gastrointestinal newco Lyric Pharmaceuticals Inc. (South San Francisco, Calif.) raised $20.4 million in a series A round led by RiverVest Venture Partners; Sante Ventures; and Third Point Ventures. Aperture Venture …

    Published on 2/26/2015
  • FINANCIAL NEWS: Relypsa raises $150M in follow-on

    Metabolic and renal play Relypsa Inc. (NASDAQ:RLYP) raised $150.2 million through the sale of 3.9 million shares at $38.50. BofA Merrill Lynch; Cowen; Oppenheimer; Stifel; and Wedbush PacGrow were underwriters. Relypsa …

    Published on 2/26/2015
  • FINANCIAL NEWS: Funding roundup: Actavis, Xencor, Curis, Celldex, AMAG

    Actavis plc (NYSE:ACT), Xencor Inc. (NASDAQ:XNCR), Curis Inc. (NASDAQ:CRIS), Celldex Therapeutics Inc. (NASDAQ:CLDX) and AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) raised more than $8.9 billion in follow-on offerings on …

    Published on 2/25/2015
  • FINANCIAL NEWS: Uptake of Orexigen's Contrave outpaces rivals

    Orexigen Therapeutics Inc. (NASDAQ:OREX) said net U.S. sales of weight-loss drug Contrave naltrexone/bupropion were $6.5 million in 4Q14, its first quarter on the market.Partner Takeda Pharmaceutical Co. Ltd. (Tokyo:…

    Published on 2/25/2015
  • FINANCIAL NEWS: CNS play Prexton closes A round

    Prexton Therapeutics S.A. (Plan les Ouates, Switzerland) raised EUR 8.7 million ($9.9 million) in a series A round co-led by new investors Sunstone Capital and Ysios Capital. Existing investor MS Ventures also …

    Published on 2/24/2015
  • FINANCIAL NEWS: China's 3SBio aims to go public again

    3SBio Inc. (Shenyang, China) proposed an IPO on the Hong Kong Stock Exchange. Morgan Stanley; Goldman Sachs; and CITIC Securities International are underwriters.3SBio was traded on NASDAQ from 2007 until 2013, when …

    Published on 2/23/2015
  • FINANCIAL NEWS: amfAR launches $100M HIV initiative

    The Foundation for AIDS Research (amfAR) pledged $20 million to establish the amfAR Institute for HIV Cure Research, an academic center dedicated to curative research, and will award $80 million in complementary …

    Published on 2/20/2015
  • FINANCIAL NEWS: Bessemer unveils $1.6B fund

    Bessemer Venture Partners raised $1.6 billion for its BVP IX fund, which the firm will invest in several sectors including therapeutics and healthcare IT.BVP's portfolio includes endocrine and metabolic play Allena …

    Published on 2/19/2015
  • FINANCIAL NEWS: Lifecode raises $20.5M series A round

    Molecular diagnostics company Lifecode Inc. (Foster City, Calif.) raised $20.5 million in a series A funding led by Sequoia Capital; the Mayo Clinic; and Mayo Ventures. The company did not respond to a request for …

    Published on 2/19/2015
  • FINANCIAL NEWS: Merganser raises $28M in series A

    Hematology play Merganser Biotech Inc. (Newtown Square, Pa.) raised $28 million in a series A round led by new investor Novartis Venture Fund. New investors Frazier Healthcare; Sutter Hill Ventures; Osage University …

    Published on 2/19/2015
  • FINANCIAL NEWS: Neurocrine raises $250M in follow-on

    Neurocrine Biosciences Inc. (NASDAQ:NBIX) raised $250 million through the sale of 6.9 million shares at $36 in a follow-on underwritten by JPMorgan; Deutsche Bank; Jefferies; Barclays; Cowen; and Nomura.Last month, …

    Published on 2/19/2015
  • FINANCIAL NEWS: ACT Genomics raises $8M series A

    ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $8 million in a series A round led by President International Development, UMC Capital, Hotong Group, TaiAn Technologies and Hua Nan Venture Capital. The company …

    Published on 2/18/2015
  • FINANCIAL NEWS: Inotek raises $60M in IPO and notes offering

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) was unchanged at $6 in its first day of trading on Wednesday after raising a combined $60 million in a downsized IPO and concurrent notes offering. Cowen; Piper Jaffray; …

    Published on 2/18/2015
  • FINANCIAL NEWS: Laguna raises $30M in B round

    Laguna Pharmaceuticals Inc. (La Jolla, Calif.) raised $30 million in a series B round led by new investors Versant Ventures and Frazier Healthcare. New investor BioMed Ventures and existing investor Sante Ventures also …

    Published on 2/17/2015
  • FINANCIAL NEWS: Quantum Genomics raises EUR 33.2M

    Quantum Genomics Corp. (Euronext:ALQGC) raised EUR 33.2 million ($37.9 million) through the sale of 5.3 million shares at EUR 6.30 in a public offering and private placement on the Alternext market of Euronext Paris …

    Published on 2/17/2015
  • FINANCIAL NEWS: Bellerophon falls after $60M IPO

    Bellerophon Therapeutics LLC (NASDAQ:BLPH) lost $3.03 (25%) to $8.97 in its first day of trading Friday after raising $60 million in an IPO on NASDAQ through the sale of 5 million shares at $12. The price valued …

    Published on 2/13/2015
  • FINANCIAL NEWS: Idera raises $75M in follow-on

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA) raised $75 million through the sale of 20 million shares at $3.75 in a follow-on underwritten by Goldman Sachs; JPMorgan; and Piper Jaffray. Idera proposed the offering after …

    Published on 2/13/2015
  • FINANCIAL NEWS: Follow-on roundup: Achillion, Atara, Threshold

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), Atara Biotherapeutics Inc. (NASDAQ:ATRA) and Threshold Pharmaceuticals Inc. (NASDAQ:THLD) have raised a combined $218.5 million in follow-ons since market close on Wednesday…

    Published on 2/12/2015
  • FINANCIAL NEWS: Inovalon, Invitae price IPOs

    Bioinformatics company Inovalon Holdings Inc. (NASDAQ:INOV) and diagnostics play Invitae Corp. (NYSE:NVTA) each began trading on Thursday after pricing bumped-up IPOs.Inovalon shares were unchanged after the company …

    Published on 2/12/2015
  • FINANCIAL NEWS: Cidara raises $42M in series B

    Infectious disease company Cidara Therapeutics Inc. (San Diego, Calif.) raised $42 million in a series B round from undisclosed new and existing institutional investors. Cidara expects to start a Phase I trial in 2H15 …

    Published on 2/11/2015
  • FINANCIAL NEWS: Israel's SteadyMed proposes $55M IPO

    SteadyMed Ltd. (Rehovot, Israel) filed to raise up to $55 million in an IPO on NASDAQ underwritten by Wells Fargo; RBC; and JMP.The company plans to submit an NDA to FDA in 1Q16 for Trevyent, a formulation of the …

    Published on 2/11/2015
  • FINANCIAL NEWS: Lux Capital targeting $350M for new fund

    Lux Capital has set a $350 million target for Lux Ventures IV, its new venture fund, according to an SEC filing. The firm, which invests in biotech and digital health as well as energy and high-tech, declined to comment…

    Published on 2/11/2015
  • FINANCIAL NEWS: TherapeuticsMD raises $55M in follow-on

    Women's health company TherapeuticsMD Inc. (NYSE-M:TXMD) raised $55 million through the sale of 13.6 million shares at $4.05 in a follow-on offering underwritten by Cowen; Stifel; and Guggenheim Securities.The company …

    Published on 2/11/2015
  • FINANCIAL NEWS: Vaxxas raises $20M in B round

    Vaxxas Pty. Ltd. (Sydney, Australia) raised $20 million (A$25.7 million) toward a planned $23.3 million (A$30 million) series B round led by existing investor OneVentures. Undisclosed new investors also participated.CEO…

    Published on 2/9/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993